Literature DB >> 25468446

Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.

S Liatis1, M Mylona2, S Kalopita3, A Papazafiropoulou4, S Karamagkiolis5, A Melidonis6, A Xilomenos7, I Ioannidis8, G Kaltsas9, L Lanaras3, S Papas4, C Basagiannis2, A Kokkinos2.   

Abstract

AIM: Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance.
METHODS: Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients' diabetes clinics of the same hospitals during the same time period.
RESULTS: Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7±10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7±18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20-1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5-6.36]), use of insulin (OR: 2.35 [1.42-3.95]), lower estimated GFR (OR: 1.15 [1.07-1.23] at 10mL/min) and number of comorbidities (OR: 1.74 [1.34-2.27]) were each independently associated with hypoglycaemia requiring medical assistance.
CONCLUSION: Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hypoglycaemia; Type 1 diabetes; Type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25468446     DOI: 10.1016/j.diabet.2014.10.006

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  2 in total

1.  Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes: A case-control study.

Authors:  Ja Young Jeon; Se Ran Kim; Hae Jin Kim; Dae Jung Kim; Kwan-Woo Lee; Jung-Dong Lee; Seung Jin Han
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

2.  Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.

Authors:  Bruno Detournay; Serge Halimi; Julien Robert; Céline Deschaseaux; Sylvie Dejager
Journal:  Vasc Health Risk Manag       Date:  2015-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.